Have a personal or library account? Click to login

The impact of concentration and administration time on the radiomodulating properties of undecylprodigiosin in vitro

Open Access
|Apr 2017

References

  1. 1. Labay E, Efimova EV, Quarshie BK, Golden DW, Weichselbaum RR, Kron SJ. Ionizing radiation-induced foci persistence screen to discover enhancers of accelerated senescence. Int J High Throughput Screen 2011:2:1-13. doi: 10.2147/IJHTS.S17076
  2. 2. Garg AK, Buchholz TA, Aggarwal BB. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal 2005;7:1630-47. doi: 10.1089/ ars.2005.7.1630
  3. 3. Hazra B, Ghosh S, Kumar A, Pandey BN. The prospective role of plant products in radiotherapy of cancer: a current overview. Front Pharmacol 2012;2:94. doi: 10.3389/ fphar.2011.00094
  4. 4. Rosenberg A, Knox S. Radiation sensitization with redox modulators: a promising approach. Int J Radiat Oncol Biol Phys 2006;64:343-54. doi: 10.1016/j.ijrobp.2005.10.013
  5. 5. Papazisis KT, Zambouli D, Kimoundri OT, Papadakis ES, Vala V, Geromichalos GD, Voyatzi S, Markala D, Destouni E, Boutis L, Kortsaris AH. Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with gamma-irradiation. Cancer Lett 2000;160:107-13. doi: 10.1016/S0304-3835(00)00569-3
  6. 6. Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer 2011;11:239-53. doi: 10.1038/nrc3007
  7. 7. Joksic G, Leskovac A, Petrovic S. Modulation of radiationinduced damage by Serbian natural plant products: implications for radioprotection. In: Arora R, editor. Herbal radiomodulators: applications in medicine, homeland defence and space. Oxfordshire: CAB International; 2008. p. 67-82.10.1079/9781845933951.0067
  8. 8. Moding EJ, Kastan MB, Kirsch DG. Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov 2013;12:526-42. doi: 10.1038/nrd4003
  9. 9. Burris HA, 3rd, Hurtig J. Radiation recall with anticancer agents. Oncologist 2010;15:1227-37. doi: 10.1634/ theoncologist.2009-0090
  10. 10. Thomson NR, Crow MA, McGowan SJ, Cox A, Salmond GP. Biosynthesis of carbapenem antibiotic and prodigiosin pigment in Serratia is under quorum sensing control. Mol Microbiol 2000;36:539-56. doi: 10.1046/j.1365-2958. 2000.01872.x
  11. 11. Hobbs G, Frazer CM, Gardner DCJ, Flett F, Oliver SG. Pigmented antibiotic production by Streptomyces coelicolor A3(2): kinetics and the influence of nutrients. J Gen Microbiol 1990;136:2291-6. doi: 10.1099/00221287-136-11-2291
  12. 12. Kawasaki T, Sakurai F, Hayakawa Y. A prodigiosin from the roseophilin producer Streptomyces griseoviridis. J Nat Prod 2008;71:1265-7. doi: 10.1021/np7007494
  13. 13. Nakamura A, Magae J, Tsuji RF, Yamasaki M, Nagai K. Suppression of cytotoxic T cell induction in vivo by prodigiosin 25-C. Transplantation 1989;47:1013-6. doi: 10.1097/00007890-198906000-00019
  14. 14. Songia S, Mortellaro A, Taverna S, Fornasiero C, Scheiber EA, Erba E, Colotta F, Mantovani A, Isetta AM, Golay J. Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets. J Immunol 1997;158:3987-95. PMID: 910347010.4049/jimmunol.158.8.3987
  15. 15. Tsuji RF, Magae J, Yamashita M, Nagai K, Yamasaki M. Immunomodulating properties of prodigiosin 25-C, an antibiotic which preferentially suppresses induction of cytotoxic T cells. J Antibiot (Tokyo) 1992;45:1295-302. PMID: 139985110.7164/antibiotics.45.12951399851
  16. 16. Pandey R, Chander R, Sainis KB. Prodigiosins as anti cancer agents: living upto their name. Curr Pharm Design 2009;15:732-41. doi: 10.2174/138161209787582192
  17. 17. Yamamoto C, Takemoto H, Kuno K, Yamamoto D, Nakai K, Baden T, Kamata K, Hirata H, Watanabe T, Inoue K. Cycloprodigiosin hydrochloride, a H+/Cl- symporter, induces apoptosis in human colon cancer cell lines in vitro. Oncol Rep 2001;8:821-4. PMID: 1141079110.3892/or.8.4.82111410791
  18. 18. Yamamoto D, Kiyozuka Y, Uemura Y, Yamamoto C, Takemoto H, Hirata H, Tanaka K, Hioki K, Tsubura A. Cycloprodigiosin hydrochloride, a H+/Cl- symporter, induces apoptosis in human breast cancer cell lines. J Cancer Res Clin Oncol 2000;126:191-7. doi: 10.1007/s004320050032
  19. 19. Chang CC, Chen WC, Ho TF, Wu HS, Wei YH. Development of natural anti-tumor drugs by microorganisms. J Biosci Bioeng 2011;111:501-11. doi: 10.1016/j.jbiosc.2010.12.026
  20. 20. Ho TF, Ma CJ, Lu CH, Tsai YT, Wei YH, Chang JS, Lai JK, Cheuh PJ, Yeh CT, Tang PC, Tsai Chang J, Ko JL, Liu FS, Yen HE, Chang CC. Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53. Toxicol Appl Pharmacol 2007;225:318-28. doi: 10.1016/j.taap.2007.08.007
  21. 21. Liu P, Wang YY, Qi X, Gu Q, Geng M, Li J. Undecylprodigiosin induced apoptosis in P388 cancer cells is associated with its binding to ribosome. PLoS One 2013;8:e65381. doi: 10.1371/ journal.pone.0065381
  22. 22. Nikodinovic-Runic J, Mojic M, Kang Y, Maksimovic-Ivanic D, Mijatovic S, Vasiljevic B, Stamenkovic VR, Senerovic L. Undecylprodigiosin conjugated monodisperse gold nanoparticles efficiently cause apoptosis in colon cancer cells in vitro. J Mater Chem B. 2014;2:3271-81. doi: 10.1039/ C4TB00300D
  23. 23. Stankovic N, Senerovic L, Ilic-Tomic T, Vasiljevic B, Nikodinovic-Runic J. Properties and applications of undecylprodigiosin and other bacterial prodigiosins. Appl Microbiol Biotechnol 2014;98:3841-58. doi: 10.1007/ s00253-014-5590-1
  24. 24. Stankovic N, Radulovic V, Petkovic M, Vuckovic I, Jadranin M, Vasiljevic B, Nikodinovic-Runic J. Streptomyces sp. JS520 produces exceptionally high quantities of undecylprodigiosin with antibacterial, antioxidative, and UV-protective properties. Appl Microbiol Biotechnol 2012;96:1217-31. doi: 10.1007/s00253-012-4237-3
  25. 25. Leiros M, Alonso E, Sanchez JA, Rateb ME, Ebel R, Houssen WE, Jaspars M, Alfonso A, Botana LM. Mitigation of ROS insults by Streptomyces secondary metabolites in primary cortical neurons. ACS Chem Neurosci 2014;5:71-80. doi: 10.1021/cn4001878
  26. 26. Boric M, Danevcic T, Stopar D. Prodigiosin from Vibrio sp. DSM 14379; a new UV-protective pigment. Microb Ecol 2011;62:528-36. doi: 10.1007/s00248-011-9857-0
  27. 27. Law on health care. Official Gazette of the Republic of Serbia. Parliament of the Republic of Serbia. 2005. 107:112-161.
  28. 28. Shukla S, Anjaria K, Bhat N, Shirsath K, Sreedevi B. Effect of caffeine on radiation induced micronuclei in human lymphocytes. Radiat Protect Environ 2010;33:195-8 [displayed 11 January 2017]. Available at http://www.rpe.org.in/article.asp?issn=0972-0464;year=2010;volume=33;issue=4;spage=195;epage=198;aulast=Shukla
  29. 29. Fenech M. The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res 1993;285:35-44. doi: 10.1016/0027-5107(93)90049-L
  30. 30. Surralles J, Xamena N, Creus A, Marcos R. The suitability of the micronucleus assay in human lymphocytes as a new biomarker of excision repair. Mutat Res 1995;342:43-59. doi: 10.1016/0165-1218(95)90089-6
  31. 31. Aebi H. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. Weinheim: Verlag Chemie; 1974. p. 673-6.10.1016/B978-0-12-091302-2.50032-3
  32. 32. Aruoma OI, Halliwell B, Laughton MJ, Quinlan GJ, Gutteridge JM. The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an iron(II)- iron(III) complex. Biochem J 1989;258:617-20. doi: 10.1042/ bj2580617
  33. 33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75. PMID: 1490771310.1016/S0021-9258(19)52451-6
  34. 34. Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci 2012;9:193-9. doi: 10.7150/ijms.3635
  35. 35. Halliwell B, Gutteridge J. Free Radicals in Biology and Medicine. 4 ed. Oxford: Oxford University Press; 2007.
  36. 36. Azzam EI, Jay-Gerin JP, Pain D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett 2012;327:48-60. doi: 10.1016/j.canlet.2011.12.012
  37. 37. Roninson IB, Broude EV, Chang B-D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001;4:303-13. doi: 10.1054/drup.2001.0213
  38. 38. Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death Differ 2008;15:1153-62. doi: 10.1038/cdd.2008.47
  39. 39. Gupte A, Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev 2009;35:32-46. doi: 10.1016/j.ctrv.2008.07.004
  40. 40. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95. doi: 10.1152/ physrev.00018.2001
  41. 41. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991;51:794-8. PMID: 1846317
DOI: https://doi.org/10.1515/aiht-2017-68-2897 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 1 - 8
Submitted on: Oct 1, 2016
Accepted on: Jan 1, 2017
Published on: Apr 1, 2017
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2017 Sandra Petrović, Vesna Vasić, Tatjana Mitrović, Saša Lazović, Andreja Leskovac, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.